Natus Medical

Natus Medical is a publicly-traded medical technology leader with a mission to advance the standard of care for neurological and sensory disorders through innovative, trusted solutions. Founded in 1987, the company has built an 80+ year legacy through strategic acquisitions of iconic neurodiagnostic brands like Nicolet, TECA, and Grass Technologies, consolidating its position in neurodiagnostics and newborn care. Its strategy revolves around a holistic, clinician-first approach that combines best-in-class hardware, proprietary software, data management, and extensive service and education to serve hospitals and clinics globally. Natus operates through two core segments: Neuro (EEG, EMG, PSG, neurocritical care) and Sensory (hearing, balance, vision, newborn care).

An integrated ecosystem of medical device hardware for electrophysiological monitoring (EEG, EMG, PSG), proprietary software for data management and analysis (e.g., NeuroWorks), and connectivity solutions, centered on diagnosing and monitoring neurological and sensory conditions.

Natus competes in fragmented segments against companies like Nihon Kohden and Cadwell in neurodiagnostics, Philips and ResMed in sleep diagnostics, and Interacoustics in sensory screening. Its advantages include a comprehensive product portfolio, trusted legacy brands, and a strong service and education network.